日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma

霍奇金淋巴瘤对布伦妥昔单抗联合伊匹木单抗和/或纳武利尤单抗治疗耐药的肿瘤免疫特征

Gonzalez-Kozlova, Edgar; Huang, Hsin-Hui; Jagede, Opeyemi A; Tuballes, Kevin; Del Valle, Diane M; Kelly, Geoffrey; Patel, Manishkumar; Xie, Hui; Harris, Jocelyn; Argueta, Kimberly; Nie, Kai; Barcessat, Vanessa; Moravec, Radim; Altreuter, Jennifer; Duose, Dzifa Y; Kahl, Brad S; Ansell, Stephen M; Yu, Joyce; Cerami, Ethan; Lindsay, James R; Wistuba, Ignacio I; Kim-Schulze, Seunghee; Diefenbach, Catherine S; Gnjatic, Sacha